Antiinfective API Market
Antiinfective API Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Antiinfective API Market Size and Growth
The Antiinfective API market is experiencing significant growth, driven by rising infectious diseases and increased pharmaceutical manufacturing. The market size is valued at approximately $XX billion in 2023, with a projected CAGR of XX% through the next five years, highlighting the need for innovative and effective therapeutic solutions globally.
Companies Covered
(Covid 19 Impact Covered)
◍ ACS Dobfar
◍ Sterile India
◍ Nectar Lifesciences
◍ Kopran
◍ Qilu Pharmaceutial
◍ Hangzhou Viwa
◍ Daewoong Bio
◍ Fresenius Kabi iPSUM
◍ Sinopharm Weiqida Pharmaceutical
◍ Virchow Healthcare
The Antiinfective API market features companies like ACS Dobfar and Fresenius Kabi focusing on R&D and production. Firms like Nectar Lifesciences and Qilu Pharmaceutical enhance market growth through diverse product portfolios. Revenue figures highlight success:
ACS Dobfar ($200M), Fresenius Kabi ($7B), and Sinopharm Weiqida ($300M).
◍ United Laboratories International Holdings
◍ Dawnrays
◍ CSPC Pharmaceutical
◍ Orchid Pharma
◍ Guangzhou Pi & Pi Biotech
Request Sample Report
Market Segmentation
By Application
Oral Medicine
Injection
Request Sample Report
By Product
Respiratory Infections API
Skin Infections API
Other
Market Growth
Request Sample Report
$ X Billion USD
